首页> 外文OA文献 >Wilms' Tumor 1 Gene Expression Using a Standardized European LeukemiaNet-Certified Assay Compared to Other Methods for Detection of Minimal Residual Disease in Myelodysplastic Syndrome and Acute Myelogenous Leukemia after Allogeneic Blood Stem Cell Transplantation

【2h】

Wilms' Tumor 1 Gene Expression Using a Standardized European LeukemiaNet-Certified Assay Compared to Other Methods for Detection of Minimal Residual Disease in Myelodysplastic Syndrome and Acute Myelogenous Leukemia after Allogeneic Blood Stem Cell Transplantation

机译：威尔姆斯的肿瘤1基因表达使用标准化的欧洲白血病认证的测定与其他方法检测骨髓增强综合征和急性霉菌白血病在同种异体血液干细胞移植后的最小残留疾病的方法相比

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Christina Rautenberg; Sabrina Pechtel; Barbara Hildebrandt; Beate Betz; Ariane Dienst; Kathrin Nachtkamp; Mustafa Kondakci; Stefanie Geyh; Dagmar Wieczorek; Rainer Haas; Ulrich Germing; Guido Kobbe; Thomas Schroeder;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
专利

1. Wilms' Tumor 1 Gene Expression Using a Standardized European LeukemiaNet-Certified Assay Compared to Other Methods for Detection of Minimal Residual Disease in Myelodysplastic Syndrome and Acute Myelogenous Leukemia after Allogeneic Blood Stem Cell Transplantation [J] . Christina Rautenberg, Sabrina Pechtel, Barbara Hildebrandt, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2018,第11期

机译：威尔姆斯的肿瘤1基因表达使用标准化的欧洲白血病认证的测定与其他方法检测骨髓增强综合征和急性霉菌白血病在同种异体血液干细胞移植后的最小残留疾病的方法相比
2. Evaluation of Minimal Residual Disease by Real-Time Quantitative PCR of Wilms' Tumor 1 Expression in Patients with Acute Myelogenous Leukemia after Allogeneic Stem Cell Transplantation: Correlation with Flow Cytometry and Chimerism [J] . KwonM., Martínez-LapercheC., InfanteM., Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2012,第8期

机译：通过实时定量PCR评估异基因干细胞移植后急性骨髓性白血病患者Wilms肿瘤1表达的最小残留疾病：与流式细胞仪和嵌合现象的相关性
3. Optimal time-points for minimal residual disease monitoring change on the basis of the method used in patients with acute myeloid leukemia who underwent allogeneic stem cell transplantation: A comparison between multiparameter flow cytometry and Wilms' tumor 1 expression [J] . Rossi Giovanni, Carella Angelo Michele, Minervini Maria Marta, Leukemia Research: A Forum for Studies on Leukemia and Normal Hemopoiesis . 2015,第2期

机译：基于异基因干细胞移植的急性髓样白血病患者使用的方法，最小残留疾病监测变化的最佳时间点：多参数流式细胞术与Wilms肿瘤1表达的比较
4. Children with acute leukemia: A comparison of outcomes and cost-effectiveness from allogeneic blood stem cell and bone marrow transplantation. [D] . Lin, Yu-Feng. 2009

机译：儿童急性白血病：同种异体造血干细胞和骨髓移植的疗效和成本效益比较。
5. Combined usage of Wilms tumor gene quantitative analysis and multiparameter flow cytometry for minimal residual disease monitoring of acute myeloid leukemia patients after allogeneic hematopoietic stem cells transplantation [O] . Yingchan Hao, Yanhong Cheng, Quan Wu, -1

机译：Wilms肿瘤基因定量分析和多参数流式细胞术的结合使用用于异基因造血干细胞移植后急性髓细胞性白血病患者的最小残留疾病监测
6. Evaluation of Minimal Residual Disease by Real-Time Quantitative PCR of Wilms’ Tumor 1 Expression in Patients with Acute Myelogenous Leukemia after Allogeneic Stem Cell Transplantation: Correlation with Flow Cytometry and Chimerism [O] . Kwon Mi, Martínez-Laperche Carolina, Infante María, 2012

机译：通过实时定量PCR评估异基因干细胞移植后急性骨髓性白血病患者Wilms肿瘤1表达的最小残留疾病：与流式细胞术和嵌合现象的相关性

Wilms' Tumor 1 Gene Expression Using a Standardized European LeukemiaNet-Certified Assay Compared to Other Methods for Detection of Minimal Residual Disease in Myelodysplastic Syndrome and Acute Myelogenous Leukemia after Allogeneic Blood Stem Cell Transplantation

著录项

引文网络

相似文献

相关主题

期刊订阅